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The end-systolic pressure-volume relation is employed to 
evaluate left ventricular contractility. In clinical studies, 
pharmacologic vasoconstriction is used to increase left 
ventricular systolic pressure to assess pressure-volume re- 
lations. However, the effect of vasoconstrictors on the 
ventricular contractile state is not well characterized. The 
effects of methoxamine and phenylephrine on systemic 
arterial pressure and left ventricular contractility in rabbits 
were studied with three protocols. 
In protocol 1, anesthetized rabbits (n = 10) were 
injected with incremental doses of methoxamine and phen- 
ylephrine intravenously. Methoxamine (4 mg) increased the 
mean arterial pressure by 50 -C 12% (mean t SE) (n = 5, 
p = 0.001). Phenylephrine (0.2 mg) increased mean arterial 
pressure by 82 -t 14% (n = 5, p = 0.004). In protocol 2, 
isolated blood-perfused hearts were injected with incremen- 
tal doses of these drugs in the ascending aorta in amounts 
approximately equal to the concentrations injected in the 
intact rabbits. Methoxamine (2 mg) reduced isovolumic 
peak systolic left ventricular pressure by 43 f 9% (n = 7, 
p = 0.003), whereas phenylephrine (0.1 mg) increased the 
isovolumic pressure by 24 + 9% (n = 7, p < 0.05). These 
responses indicated an enhanced contractile state with 
phenylephrine and a reduced contractile state with meth- 
The end-systolic pressure-volume relation is an index of left 
ventricular contractility that is relatively independent of 
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oxamine. Pretreatment with propranolol blunted the effect 
of phenylephrine on isovolumic pressure (n = 6, p < 0.02). 
In protocol 3, cross-circulation experiments allowed 
study of the effect of these drugs on isovolumic left ventric- 
ular pressure in the isolated heart and simultaneously on 
the systemic arterial pressure in the intact anesthetized 
rabbit (support rabbit). Methoxamine decreased isovolu- 
mic left ventricular pressure at infusion rates that increased 
mean arterial pressure in the support rabbit. With phenyl- 
ephrine, both the left ventricular isovolumic pressure and 
the mean arterial pressure increased. 
Thus, in the isolated supported heart, phenylephrine 
increased left ventricular contractility at doses that pro- 
duced peripheral vasoconstriction in the intact rabbit. 
Conversely, methoxamine reduced ventricular contractility 
in the isolated heart at doses that produced peripheral 
vasoconstriction in the intact rabbit. The isolated hearts 
had variable susceptibility to the depressant effect of meth- 
oxamine. These results demonstrated the allowable range 
for valid results and the limitations of using pharmacologic 
vasoconstricting agents to manipulate arterial pressure 
afterload when assessing left ventricular contractility in thii 
model and possibly in humans. 
(.I Am Co11 Cardiol1989;14:1350-8) 
preload volume and is sensitive to changes in inotropy (1). In 
the intact animal and in humans, pharmacologic vasocon- 
striction with methoxamine or phenylephrine is commonly 
employed to increase the ventricular pressure afterload to 
determine pressure-volume relations (2-4). However, the 
direct effects of these drugs on the myocardial contractile 
state are understood incompletely. A valid estimate of 
ventricular contractility is not possible if these agents modify 
contractility. In animals, phenylephrine increases myocar- 
dial contractility (5-10). However, the data for methoxamine 
are more controversial (11); some investigators reported 
minimal effects (12), whereas others found dose-related 
myocardial stimulation or depression (13-18). Further, the 
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effects of methoxamine on pressure-volume relations in an 
ejecting heart preparation (19) may be related to the heart or 
the arteries, or both (20). 
To clarify and quantitate the myocardial and systemic 
efects of methoxamine andphenylephrine, we employed the 
intact rabbit, the isolated isovolumic rabbit heart and a 
cross-circulation experiment in which we assessed contrac- 
tility in the isolated isovolumic heart and arterial pressure in 
the intact rabbit simultaneously. 
Methods 
Experimental protocols. New Zealand white rabbits 
weighing 2.5 to 5 kg were anesthetized with intravenous 
pentobarbital (50 mg/kg body weight). Intravascular pres- 
sures were registered by pressure transducers (Gould, series 
P23Db) and recorded on a strip chart recorder (Gould, model 
2400s) running continuously at 1 mm/s. Three types of 
protocols were performed: in protocol 1, blood pressure 
dose-response curves were determined in intact anesthetized 
rabbits. In protocol 2, left ventricular isovolumic pressure 
dose-response curves were evaluated in isolated rabbit 
hearts. These studies were designed to study the effects of 
the approximate concentrations found during the protocol 1 
on contractile state. In protocol 3, a cross-circulation study 
was performed with an isolated heart and a support rabbit. 
This protocol was designed to assess simultaneously the 
effects of these drugs on arterial pressure in the intact 
support rabbit and on left ventricular isovolumic pressure in 
the isolated heart, with use of the isolated heart as a 
bioassay. 
For the dose-response curves, we used log serial dilutions 
in saline solution of methoxamine hydrochloride (20 mg/ml) 
(Vasoxyl, Burroughs Wellcome) or of phenylephrine hydro- 
chloride (10 mg/ml) (NeoSynephrine, Winthrop Breon). The 
drugs had similar molecular weights (247.72 versus 203.67 
g/mole, respectively), but the concentration of methoxamine 
per ampule was double that of phenylephrine. 
Protocol 1: intact rabbit preparation. After anesthesia, 
catheters were placed in the common carotid artery and the 
internal jugular vein in 10 rabbits. After 210 min of stable 
arterial pressure recording, a series of increasing concentra- 
tions of either phenylephrine or methoxamine were injected 
(in five rabbits for each) in the internal jugular vein with use 
of 0.2 ml per bolus and allowing 1 to 2 min between 
injections. Only one drug was injected into each animal. In 
three additional rabbits the stability of the arterial blood 
pressure was assessed for 40 min, the time necessary to 
perform the dose-response studies. The average decrease in 
the mean arterial pressure was 4%. 
Protocol 2: isolated heart preparation. After anesthesia, 
14 rabbits were ventilated through a tracheostomy with a 
mechanical ventilator (Harvard Apparatus, model 681) and 
intravenous heparin was administered for anticoagulation. 
Approximately 100 to 150 ml of blood was withdrawn 
through a femoral artery catheter to prime the isolated heart 
perfusion system. Half this volume was replaced with nor- 
mal saline solution and half with perfluorocarbon (FC-43, 
Alpha Therapeutic Company). The chest was opened by 
midline sternotomy. The heart was exposed and a cannula 
inserted into the aorta. The superior and inferior venae 
cavae, the azygos vein and the pulmonary arteries were 
ligated. The heart and lungs were excised and suspended by 
the aortic cannula in a constant temperature chamber that 
was heated by a water bath to approximately 30°C. Blood 
drawn from a reservoir with use of a roller pump (Cole- 
Parmer, model 7562-10) was pumped to the heart at constant 
flow through an oxygenation chamber (97% oxygen, 3% 
carbon dioxide), and a 40 p filter (Pall, model SQ4OS), 
leading to the aortic cannula. The lungs were removed. A 
polyethylene cannula was placed in the right ventricle from 
the pulmonary artery to return the coronary blood flow to 
the reservoir. A prestressed balloon attached to a catheter 
was inserted through the mitral valve into the left ventricle 
and inflated with a calibrated syringe. A thin polyethylene 
cannula was inserted adjacent to the balloon to vent blood 
from the Thebesian flow or possible occasional aortic regur- 
gitation. Pressure transducers were connected to the aortic 
and left ventricular catheters. Small electrodes were clipped 
to the left atrium for overdrive electrical stimulation at rates 
of 90 to 120/min, selected to optimize force development 
(Grass, model SD9). The preparation was similar to that 
used previously in this laboratory (21). 
When the isovolumic systolic pressure was stable, bolus 
injections (0.1 ml each) of serial concentrations of either 
methoxamine or phenylephrine solution were injected (in 
seven preparations each) into the aortic cannula, starting 
from the most dilute, allowing sufficient time between doses 
to achieve stable isovolumic left ventricular pressure (usu- 
ally 1-5 min). Only one drug was injected into each prepa- 
ration. The arterial pH, PO,, Pco, and bicarbonate concen- 
tration were measured periodically. The pH was maintained 
at physiologic levels with injections of sodium bicarbonate 
into the venous return of the circuit as necessary. In six 
phenylephrine studies 0.2 mg of propranolol was injected 
after the I mg dose of phenylephrine. Then 1 mg of phenyl- 
ephrine was reinjected. In two additional hearts the stability 
of the isolated heart preparation was assessed for an average 
period of 63 minutes. The isovolumic pressure decreased 
4.7% and the coronary perfusion pressure increased 4.9%. 
This period exceeded the average of 36 min necessary to 
perform the dose-response studies. 
Protocol 3: isolated supported heart preparation (Fig. 1). 
The isolated heart was prepared as outlined in protocol 2. In 
parallel a “support rabbit” was anesthetized and instru- 
mented with a needle in an ear vein for pentobarbital 
injection, a tracheostomy for ventilation, a carotid artery 
cannula and an internal jugular vein cannula for pressure 
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Figure 1. Isolated supported heart 
(protocol 3). The support rabbit (left) is 
shown with bilateral femoral artery 
cannulas leading arterial blood to a 
VE 
OXYGENATOR roller pump and then to the isolated 
BUBBLE TRAP heart (right), which was suspended in a 
constant temperature water bath. 
Venous efflux through the coronary 
sinus was recirculated to the femoral 
veins with an additional roller pump. 
The blood level in the reservoir of the 
constant temperature bath was held 
;i!?:^,h constant by adjusting the venous (IV) 
roller pump. In the isolated heart, aor- 
tic pressure, as a measure of coronary 
perfusion pressure (CPP) and left ven- 
tricular isovolumic pressure (LVP), 
were recorded. Left ventricular vol- 
ume (LVV) was controlled by a bal- 
loon in the left ventricle. In the support 
rabbit, the arterial pressure (ART. BP) 
and central venous pressure (CVP) 
were monitored. For the simpler iso- 
lated perfused heart protocol, an oxy- 
genator replaced the support rabbit and 
the venous roller pump was eliminated, 
as shown by the dashed lines. 
monitoring, along with bilateral femoral artery and vein 
cannulas for cross-circulation. Indomethacin (3 mg/kg) was 
mixed with approximately 6 mg sodium carbonate, dissolved 
in approximately 5 to 8 ml normal saline solution and 
injected intravenously into the rabbit. When the isolated 
heart and the intact rabbit were stable individually, cross- 
circulation was established by substituting the support rabbit 
for the oxygenator in the circuit. The residual blood in the 
oxygenator was re-infused into the circuit (Fig. 1). One roller 
pump maintained a constant blood flow to the isolated heart. 
The other adjusted venous return to the support rabbit so 
that a stable blood volume was present in each part of the 
circuit. This adjustment was achieved by close observation 
of the blood level in the reservoir with small modifications of 
the venous flow rate to keep the level constant. (For the 
isolated heart studies in protocol 2, the oxygenator com- 
pleted the circuit instead of the support rabbit, and one less 
roller pump was employed.) The preparation was similar to 
that used previously in this laboratory (22). The temperature 
on the inner surface of the heart was monitored before the 
experiment with use of a digital thermometer and was 
adjusted and maintained at 35 to 37°C by adjusting the water 
bath temperature. The temperature was checked afterward 
and was constant. Drugs were infused into the intact rabbit 
through the femoral vein (“intravenous administration”) or 
into the isolated heart through the femoral artery cannula 
(“infusion line administration”) with a calibrated infusion 
pump (Harvard, model 56-8808). The arterial pressure, cen- 
tral venous pressure, coronary perfusion pressure and iso- 
lated heart pressure were recorded continuously at a paper 
speed of 1 mm/s. 
In a control experiment, we studied pressures in the 
isolated supported heart preparation. Over a 2 h period, the 
mean arterial pressure of the support rabbit decreased 9.5%, 
isovolumic left ventricular systolic pressure increased 11.3% 
and coronary perfusion pressure increased 4.6%. This period 
was approximately twice that necessary to perform the 
experiments. 
Data analysis: dose-response curves. For the intact rabbits 
(protocol l), the mean arterial pressure was measured by 
electronic low pass filtering or was calculated as the diastolic 
blood pressure plus one third of the pulse pressure. The 
blood volume in intact rabbits was estimated to be approx- 
imately 200 ml (23). The blood volume in the perfusion 
circuit was 100 ml excluding the heart and aorta (approxi- 
mately 10 to 20 ml). To achieve a rough equivalency of drug 
dosage, we injected twice the amount of drug into the intact 
rabbit as that injected into the isolated hearts (protocol 2). 
However, we expressed the cumulative dose-response 
curves in terms of the injected doses, because we could not 
estimate accurately the volume of distribution on the first 
passage of the drug. With use of the calculated distribution 
volume at equilibrium, multiplying by the factor 10m4 would 
convert the milligram dosage to its molar concentration. The 
maximal effect of each drug was assessed after each bolus 
injection. We expressed the effect of each dose as a percent 
of the baseline pressure before the first drug injection. For 
the isolated supported heart studies (protocol 3), we plotted 
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Figure 2. Phenylephrine and methoxamine in 
the intact animal (protocol I). Dose-response 
curves for phenylephrine (A) and methoxamine 
(B) demonstrate the percent change in mean 
arterial pressure (MAP) as a function of injected 
dose (mg). The response to methoxamine was 
blunted compared with the response to phenyl- 
ephrine. There was no further increase in mean 
arterial pressure after the largest methoxamine 
injection. 
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the simultaneous support rabbit and isolated heart pressures. 
We judged that the preparation was responsive and the 
results valid if the mean arterial pressure of the support 
rabbit increased by 2 10% during drug infusion. 
Statistical analysis. Numerical data were entered into a 
medical data base system (CLINFO), supplied to the 
Vanderbilt Clinical Research Center by the Division of 
Research Resources, National Institutes of Health. The data 
were analyzed by analysis of variance with adjustment for 
repeated measures. When significant F statistics were de- 
tected, paired t tests were performed, comparing the pres- 
sure responses with control values. Results are reported as 
mean value, +SEM. A statistically significant difference was 
considered to exist when p < 0.05. 
Results 
Protocol 1. In protocol 1 (arterial pressure dose-response 
study), we administered each drug to five rabbits (Fig. 2). 
The mean arterial pressure increased progressively with 
increasing doses of phenylephrine up to 0.2 mg (Fig. 2A), 
which was associated with an increase in pressure of 82% t 
14% (p = 0.004). With a 2 mg dose, each of two rabbits died 
suddenly. With methoxamine, the mean arterial pressure 
increased more slowly up to concentrations of 0.04 mg but 
increased sharply by 52% -+ 6% with the 0.4 mg dose (p = 
0.001). Paradoxically, there was no further increase in the 
mean arterial pressure after the 4 mg dose (Fig. 2B). Fre- 
quently with 0.4 mg and 4 mg injections, the arterial pressure 
decreased transiently before increasing (data not shown). 
Phenylephrine increased the arterial pressure more than 
similar dilutions of methoxamine (p = 0.03) with use of the 
Wilcoxon non-parametric rank sums test. 
Protocol 2. In protocol 2, we administered each drug to 
seven isolated hearts (Fig. 3). Because the left ventricular 
end-diastolic pressure was always <.5 mm Hg and remained 
constant throughout each study, the changes in peak systolic 
pressure corresponded to changes in developed pressure 
(data not shown). Coronary blood flow was maintained 
constant. The left ventricular isovolumic systolic pressure 
increased significantly after bolus additions of 0.01 to 1 mg 
phenylephrine to the coronary circulation (Fig. 3A). In 
contrast, the effects of methoxamine were qualitatively 
different (Fig. 3B). The isovolumic pressure increased 
slightly but significantly at doses of 2 x lo-” mg and 2 x 
10-j mg but then decreased gradually, though insignifi- 
cantly, at doses of 2 x lo-’ mg, 2 x 10e2 mg, and 2 x 10-l 
mg. After the latter dose, the systolic pressure decreased by 
9% ? 14% (p = NS), but with the 2 mg dose it decreased by 
43% 2 9% (p = 0.003). 
The similarity of the curves in Figures 2A and 3A sug- 
gests that there were similar effects of phenylephrine on 
blood pressure and contractile state. In contrast, the effects 
of methoxamine were more complex. This drug progres- 
A. 
60 
Figure 3. Phenylephrine and methoxamine in the iso- %5o 
lated heart (protocol 2). The format is similar to that of ?I 
Figure 2. For phenylephrine (A) the left ventricular 
systolic pressure (LVSP) increased progressively with 
$yo 
z 
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Figure 4. Response to phenylephrine before and after propranolol 
(protocol 2). The positive inotropic response to 1 mg phenylephrine 
was eliminated after administration of 0.2 mg propranolol. 
sively increased mean arterial pressure in the intact rabbit 
except for a plateau at its highest dose (Fig. 2B); methox- 
amine decreased isovolumic pressure in the isolated heart at 
a similar high dose (Fig. 3B). 
The effects of phenylephrine on left ventricular isovolu- 
mic pressure in six isolated hearts before and after beta- 
adrenergic blockade with propranolol are shown in Figure 4. 
Before propranolol, phenylephrine (1 mg) increased the 
systolic pressure by 27 + 7% (p = 0.01). After 0.2 mg 
propranolol, the pressure decreased by 23% + 7% from 
control (p = 0.02) to a new baseline. A second 1 mg bolus of 
phenylephrine did not increase the systolic pressure signifi- 
cantly (4 + 2%, p = NS) from the new baseline. 
Protocol 3. In protocol 3 (isolated supported heart), we 
administered methoxamine into the isolated heart infusion 
line in nine preparations; in five of these we also used 
intravenous methoxamine. We administered phenylephrine 
in two hearts, intravenously in one heart and through the 
infusion line in another. Typical examples are shown in Fig. 
5, which demonstrates three preparations. During adminis- 
tration of intravenous phenylephrine (Fig. 5A), the left 
ventricular isovolumic systolic pressure and the support 
rabbit mean arterial pressure increased in parallel as the 
infusion rate increased. The rabbit systolic arterial pressure 
decreased quickly after the infusion was discontinued; how- 
ever, the isovolumic left ventricular systolic pressure con- 
tinued to increase for several more minutes before decreas- 
ing. The coronary perfusion pressure and end-diastolic 
pressure of the isolated heart were constant throughout the 
study. During administration of intravenous methoxamine 
(Fig. 5B) the support rabbit mean arterial pressure increased 
by 25%, whereas the left ventricular isovolumic systolic 
pressure decreased by 18% from control. During administra- 
tion of methoxamine into the isolated heart infusion line 
(Fig. SC), the left ventricular isovolumic pressure decreased 
by 59%, whereas the rabbit systolic arterial pressure in- 
LVSP 
0 5 IO I5 20 
TIME WIN) 
B. 
ISOr 
Oobt I5 I I I I 1 I 20 25 30 35 40 
TIME (MINI 
SBP (*29=/J 
I 
17 25 30 
TIME (MINI 
Figure 5. Isolated supported heart preparations (protocol 3). A, 
Response to intravenous (IV) phenylephrine. The systolic blood 
pressure (SBP) in the support rabbit and the isovolumic left ventric- 
ular systolic pressure (LVSP) in the isolated heart increased in 
parallel during the infusion. The coronary perfusion pressure (CPP) 
was constant. B, Response to intravenous methoxamine. The mean 
arterial pressure (MAP) increased by approximately 30 mm Hg 
(25%). Simultaneously, left ventricular systolic pressure decreased 
by approximately 20 mm Hg (18%); the coronary perfusion pressure 
was relatively stable. The rabbit and heart pressures returned to 
baseline after the infusion (INF) was discontinued. C, Response to 
methoxamine through the infusion line. The reduction in left ven- 
tricular systolic pressure was more pronounced than that by the 
intravenous route. At the end of the infusion, the support rabbit 
systolic blood pressure had increased 2% above control level, 
whereas left ventricular systolic pressure had decreased by 59%. 
Pressures returned toward control values after ending the infusion. 
BEG. = begin; INC = increased. 
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% CHANGE LVSP 
Figure 6. Summary of effects of methoxamine. Paired results are 
shown for the five preparations (1 to 5) with both intravenous (IV) 
and infusion line (intra-arterial [IA]) administration, shown with 
equal infusion rates. There was a broad range of responses. The 
support rabbit mean arterial pressure (MAP) increased more after 
intravenous infusion (66%) than after intra-arterial (33%). The 
isolated heart left ventricular systolic pressure (LVSP) decreased 
more after intra-arterial infusion (25%) than after intravenous (5%). 
The dashed line demonstrates further depression of left ventricular 
systolic pressure in preparation 3 after an increment in the intrave- 
nous infusion rate (3’); this decrease was similar to the decrease 
after intra-arterial infusion. 
creased by 29%. Pressures returned toward control values 
after the infusion was discontinued. 
For the nine preparations in which methoxamine was 
administered into the isolated heart infusion line, the mean 
maximal increase in mean arterial pressure of the support 
rabbits was 36 + 5% (p < 0.001) and the mean maximal 
decrease in left ventricular isovolumic systolic pressure was 
31 t 5% (p < 0.001). In the five preparations with intrave- 
nous methoxamine infusions, the mean maximal increase in 
mean arterial pressure of the support rabbits was 65 ? 14% 
(p = 0.009), whereas the mean maximal decrease in the 
systolic pressure in the isolated hearts was 10 ? 6% (p = 
NS). 
Figure 6 compares the results of intravenous and infusion 
line administration of methoxamine at equal infusion rates 
in five preparations. The mean arterial pressure increased 
more during intravenous administration (66 + 14%) than 
during infusion line administration (33 t 9%) (p = 0.04). 
The isolated heart systolic pressure decreased more during 
infusion line administration (25 * 5%) than during intrave- 
nous administration (5 t 4%) (p = 0.005); the 5% decrease 
was not significant statistically. In a single preparation 
(preparation 3), the intravenous infusion rate was increased 
to a rate greater than the prior infusion line rate (point 3’). 
With this increase, the left ventricular systolic pressure 
decreased sharply, and to a similar degree as during direct 
administration into the infusion line, suggesting a concentra- 
tion effect. 
Discussion 
Effect of vasoconstrictor drugs on left ventricular contrac- 
tility. Pharmacologic afterload stress has been used to as- 
sess left ventricular contractility by systolic pressure- 
volume relations (2,19,20,24), force-velocity relations (4) 
and stroke work (25). Pharmacologic pressure afterloading 
by administration of vasoconstrictors is convenient and 
simple, but these agents may have two types of effects- 
direct effects on the left ventricular contractile state and 
indirect effects on the end-systolic pressure-volume relation 
due to changes in arterial resistance (19,20,24). This study 
clarifies and extends the available data regarding direct 
effects of methoxamine and phenylephrine on contractility. 
The additional effects on the left ventricular systolic pres- 
sure-volume relations in the intact circulation were not 
assessed. 
Predictably, both phenylephrine and methoxamine in- 
creased the systemic arterial blood pressure in the intact 
rabbit, but they affected contractility of the isolated heart 
and in different manners. Phenylephrine had a positive 
inotropic effect. Methoxamine had a mixed cardiac inotropic 
effect, slightly positive at low concentrations, insignificant at 
medium concentrations but markedly negative at the higher 
concentrations. The threshold for altering blood pressure in 
the intact rabbit approximated the threshold for affecting left 
ventricular isovolumic pressure in the isolated heart (Fig. 2 
and 3). The cross-circulation experiments demonstrated 
these effects simultaneously and confirmed that phenyleph- 
rine and methoxamine had independent peripheral arterial 
and direct cardiac effects. 
Alpha-receptor agonists cause peripheral arterial vaso- 
constriction (26). Cardiac alpha-adrenergic receptors are 
present in several species (cat, rat, dog, rabbit) (5,7,8,27). 
Although the number of these receptors in the heart is 
relatively small compared with that of beta-adrenergic re- 
ceptors (27), alpha-adrenergic stimulation can also exert 
positive inotropic effects (5,7-9,15-17,28,29). 
Phenylephrine. This drug has both alpha- and beta- 
adrenergic effects in the heart (5,7,15,29). Schumann et al. 
(7) found that the positive inotropic effects were mediated by 
alpha-adrenergic receptors at low drug concentrations and 
by beta-adrenergic receptors at high concentrations, but 
Bruckner et al. (8) concluded that phenylephrine acted 
exclusively on cardiac alpha-adrenergic receptors. Our 
study confirmed that beta-adrenergic receptor stimulation 
mediated the cardiac effect of phenylephrine in high concen- 
trations (Fig. 4). We did not address the mechanism at low 
concentrations. 
In intact anesthetized dogs, phenylephrine increased the 
arterial diastolic pressure and the right ventricular force of 
contraction (30). More recently, Tajimi et al. (10) showed in 
dogs that phenylephrine increased contractility as assessed 
by end-systolic pressure-volume relations. The response 
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was blocked by propranolol and appeared to be a beta- 
adrenergic effect. In 12 normal human subjects, we also 
found similar leftward shifts of systolic pressure-volume 
relations at high infusion rates of phenylephrine; these shifts 
were blocked by propranolol (p = 0.02) (31). The present 
study confirmed these findings and suggests that phenyleph- 
tine has cardiac beta-adrenergic effects and induces periph- 
eral alpha-adrenergic stimulation. Sodums et al. (24) found 
that angiotensin II shifted the left ventricular pressure- 
volume relation leftward, parallel to that in control animals. 
This shift might be an expression of positive cardiac inotropy 
in the intact dog, but also might be due to effects on the 
arterial resistance alone. Large changes in resistance can 
produce parallel shifts in ventricular pressure-volume rela- 
tions in the ejecting isolated supported heart (20). The 
present study expands on this work by demonstrating posi- 
tive inotropic effects in the isovolumically contracting iso- 
lated heart. 
Methoxamine. The blood pressure dose-response curves 
for methoxamine were shifted to the right compared with 
those obtained at equal doses of phenylephrine (Fig. 2) as 
demonstrated by others (26). In the isolated heart, we 
observed a multiphasic response to methoxamine, initially a 
small positive inotropic effect, then no net effect, followed 
by a significant negative inotropic effect as the dose was 
increased. These results are consistent with prior studies in 
various cardiac preparations. Endoh and Schumann (15) 
found that methoxamine produced a dose-dependent posi- 
tive inotropic effect in the rabbit papillary muscle that was 
most apparent at low concentrations, low stimulation fre- 
quencies and low temperatures. There was a marked nega- 
tive inotropic effect at higher concentrations. Phentolamine 
antagonized the positive inotropic effect, implying alpha- 
adrenergic mediation. Such responses have been confirmed 
in the rabbit papillary muscle (9) and cat papillary muscle 
(16). Others found that methoxamine depressed cardiac 
force in a dose-dependent manner in anesthetized dogs 
(13,14) and neonatal sheep (18), and decreased the slope of 
the end-systolic pressure-volume relation in conscious dogs 
(19), consistent with a negative inotropic effect. Because the 
effects of methoxamine on the heart in intact animals (19) 
might also be influenced by acute changes in the peripheral 
vascular resistance (20), the present study is especially 
helpful in implicating a direct cardiac effect. We found 
negative inotropic effects of methoxamine on isovolumic 
pressure both in the isolated heart and in the isolated 
supported heart. 
Clinical studies of left ventricular contractility have em- 
ployed methoxamine because of earlier work (12) that 
showed few effects on right ventricular contractile force in 
cardiac patients at thoracotomy. Goldberg et al. (12), using 
strain gauges in contracting hearts, found only slight changes 
in right ventricular contractile force (-9% to +180/o), 
whereas the systemic systolic pressure increased by 16 to 65 
mm Hg. There were no measurements of right ventricular 
pressure, volume or rate of rise of isovolumic pressure, and 
thus their work could not assess directly the effects of 
methoxamine on myocardial contractility. Interestingly, af- 
ter 2 mg methoxamine, the systemic arterial pressure de- 
creased transiently before increasing (their Fig. 3). This 
response suggests transient cardiac depression and is analo- 
gous to our results in the intact rabbit and to the depression 
of isovolumic systolic pressure in the isolated heart. 
Possible mechanism for the methoxamine effect. There has 
been considerable speculation about this mechanism be- 
cause of the unusual combination of positive and negative 
inotropic effects (11,15,16). The positive inotropic effects 
may be due predominantly to alpha-adrenergic stimulation 
(9,15-l&28), but there may be several mechanisms to ex- 
plain the negative inotropic effect. Imai (32) found that large 
concentrations of methoxamine reduced phase 0 depolariza- 
tion by a “local anesthetic effect” on sodium conductance, 
which would be expected to reduce calcium entry and 
reduce contractility (14). However, other studies (14,33) 
have shown that methoxamine competitively antagonizes 
the chronotropic and inotropic effects of epinephrine, sug- 
gesting an underlying beta-adrenergic blocking effect. Coro- 
nary vasoconstriction may also mediate the negative inotro- 
pit effect. In dogs, methoxamine increases the coronary 
vascular resistance at systemic pressor doses (34), and a 
recent study (35) showed that intracoronary methoxamine 
increases coronary vascular resistance, decreases left ven- 
tricular ejection fraction and produces ST segment changes 
suggestive of myocardial ischemia. In the present study, the 
stability of the coronary perfusion pressure during constant 
coronary flow implied that direct myocardial effects were 
more important than coronary vasoconstriction in decreas- 
ing left ventricular isovolumic pressure. However, this study 
did not address the mechanism of the inotropic effects of 
methoxamine. 
Clinical studies (4) of left ventricular force-velocity rela- 
tions employ infusion rates of methoxamine up to 1 mg/min, 
which increase the systolic arterial pressure by 30 to 60 mm 
Hg. On the basis of the present study, the larger changes in 
arterial pressure would be associated with a greater likeli- 
hood of a negative inotropic effect of methoxamine on the 
myocardium. However, because we found that individual 
hearts had variable susceptibility to the depressant effects of 
methoxamine (Fig. 6), it is difficult to predict that there 
would be a fixed threshold for this depression. The depres- 
sant effects are not limited to the rabbit because we found 
that intravenous infusion of methoxamine depressed left 
ventricular systolic pressure in preliminary experiments in 
canine isolated supported hearts (Fig. 7). 
Differences between intravenous and infusion line admin- 
istration of metboxamine. The isovolumic pressure of the 
isolated supported heart decreased more by administering 
methoxamine directly into the infusion line than by admin- 
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Figure 7. Intraaortic (“intracoronary” [ICI) and in- 
travenous (IV) methoxamine in a canine isolated 
supported heart preparation. Three dogs were stud- 
ied in preliminary experiments. During intravenous 
(IV) infusion, the left ventricular systolic pressure 
(LVSP) decreased by 18.7 t 2.9% (p = 0.02), 
whereas simultaneously the mean arterial pressure 
(MAP) of the support dog increased by 14.2 ? 1.8% 
(p < 0.02). This figure illustrates typical changes in 
one experiment. Serial intracoronary injections of 
0.2 mg and 2 mg of methoxamine decreased left 
ventricular systolic pressure transiently and in- 
creased coronary perfusion pressure (CPP) tran- 
siently. During intravenous infusion, left ventricular 
systolic pressure decreased and mean arterial pres- 
sure increased, whereas coronary perfusion pressure 
decreased slightly. These changes resolved after 
discontinuation of the infusion. 
istering methoxamine intravenously to the support rabbit. 
Conversely, the arterial pressure of the support rabbit in- 
creased more by administering methoxamine intravenously 
to the support rabbit rather than directly to the isolated 
heart. These results might occur if the drug were taken up by 
structures such as the lungs, heart and peripheral arteries, 
thus enhancing local effects either in the isolated heart or in 
the arteries of the support rabbit, depending on the route of 
administration. Regardless of whether such structures take 
up methoxamine, our results show that the cardiac depres- 
sant effect of methoxamine may actually occur at the con- 
centrations that correspond to those required for peripheral 
vasoconstriction in the support rabbit. The effect on the 
isolated heart may simply be visible more easily than in the 
intact circulation. Unfortunately, no assay is available for 
methoxamine at in vivo concentrations; therefore, it is not 
currently possible to elucidate the mechanism further. 
60 
Advantages and limitations of study design. The three 
protocols we used allowed evaluation of the dosages of 
phenylephrine and methoxamine that were necessary to 
achieve effects in the peripheral circulation, the myocardium 
and simultaneously in the isolated heart and intact anesthe- 
tized rabbit by cross-circulation studies. These effects oc- 
curred during infusions, rather than only with bolus admin- 
istration of the drugs. It is possible that the effects of 
methoxamine were accentuated by the depressant effects of 
pentobarbital anesthesia (36), but methoxamine also has a 
negative inotropic effect in the conscious dog (19). 
Conclusions. This study shows more clearly than previ- 
ously that when vasoconstricting drugs such as phenyleph- 
tine and methoxamine are used to assess left ventricular 
contractility, there may be direct effects on the myocardium. 
Phenylephrine might be best employed after beta-adrenergic 
blockade. Methoxamine might be best employed at low 
concentrations to minimize its direct myocardial effects. 
However, it should be recognized that physiologically sig- 
nificant alterations in myocardial inotropy may occur at 
TIME (MN) 
concentrations that cause moderate changes in the systemic 
arterial pressure. 
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